press releases Press Releases Harbinger Health Announces New Partnership with Leading Cancer Center to Accelerate Clinical Evidence Generation November 7, 2024 Perspectives | Press Releases Harbinger Health Begins New Clinical Study in Individuals at High Risk for Cancer December 5, 2023July 10, 2024 Press Releases Harbinger Health Raises $140 Million in Series B Funding to Accelerate Advancement of its Screening Platform for Early-Stage Cancers September 28, 2023August 1, 2024 Press Releases Harbinger Health Expands Industry-Leading Executive Team September 6, 2023May 22, 2024 Press Releases Harbinger Health Announces Data Demonstrating Its Ability to Detect Early-Stage Multi-Cancer at the AACC Annual Scientific Meeting 2023 July 26, 2023May 1, 2024 Press Releases Harbinger Health Appoints May Orfali, M.D. as Chief Medical Officer May 23, 2023May 1, 2024 Press Releases Harbinger Health Announces Results Demonstrating High-Sensitivity of Early Stage Multi-Cancer Detection Platform at ASCO Annual Meeting 2023 April 25, 2023July 1, 2024 Press Releases Harbinger Health Appoints Vincent Lozada as Chief Financial Officer February 13, 2023May 1, 2024 Press Releases Harbinger Health and Sarah Cannon Research Institute Launch Clinical Study to Validate and Advance Development of Harbinger’s Novel Early Cancer Detection Platform June 29, 2022May 1, 2024 Press Releases Flagship Pioneering Launches Harbinger Health to Detect Early Cancer with a Simple, Bio-AI Based Blood Test December 7, 2021May 1, 2024 perspectives Perspectives Understanding PPV and NPV in Healthcare Testing: Crucial Tools for Diagnostic Accuracy September 26, 2024September 27, 2024 Perspectives “Reflexing” in The Right Direction: Two-Tier Testing for Early Cancer Screening August 1, 2024August 7, 2024 Perspectives A Conversation About Access. July 10, 2024July 11, 2024 Perspectives | Press Releases Harbinger Health Begins New Clinical Study in Individuals at High Risk for Cancer December 5, 2023July 10, 2024
Press Releases Harbinger Health Announces New Partnership with Leading Cancer Center to Accelerate Clinical Evidence Generation November 7, 2024
Perspectives | Press Releases Harbinger Health Begins New Clinical Study in Individuals at High Risk for Cancer December 5, 2023July 10, 2024
Press Releases Harbinger Health Raises $140 Million in Series B Funding to Accelerate Advancement of its Screening Platform for Early-Stage Cancers September 28, 2023August 1, 2024
Press Releases Harbinger Health Expands Industry-Leading Executive Team September 6, 2023May 22, 2024
Press Releases Harbinger Health Announces Data Demonstrating Its Ability to Detect Early-Stage Multi-Cancer at the AACC Annual Scientific Meeting 2023 July 26, 2023May 1, 2024
Press Releases Harbinger Health Appoints May Orfali, M.D. as Chief Medical Officer May 23, 2023May 1, 2024
Press Releases Harbinger Health Announces Results Demonstrating High-Sensitivity of Early Stage Multi-Cancer Detection Platform at ASCO Annual Meeting 2023 April 25, 2023July 1, 2024
Press Releases Harbinger Health Appoints Vincent Lozada as Chief Financial Officer February 13, 2023May 1, 2024
Press Releases Harbinger Health and Sarah Cannon Research Institute Launch Clinical Study to Validate and Advance Development of Harbinger’s Novel Early Cancer Detection Platform June 29, 2022May 1, 2024
Press Releases Flagship Pioneering Launches Harbinger Health to Detect Early Cancer with a Simple, Bio-AI Based Blood Test December 7, 2021May 1, 2024
Perspectives Understanding PPV and NPV in Healthcare Testing: Crucial Tools for Diagnostic Accuracy September 26, 2024September 27, 2024
Perspectives “Reflexing” in The Right Direction: Two-Tier Testing for Early Cancer Screening August 1, 2024August 7, 2024
Perspectives | Press Releases Harbinger Health Begins New Clinical Study in Individuals at High Risk for Cancer December 5, 2023July 10, 2024